ESTROGEN REPLACEMENT THERAPY FOR STROKE. [PDF]
Cell Med, 2014 Stroke is the third most common cause of death and severe disability among Western populations. Overall, the incidence of stroke is uniformly higher in men than in women. Stroke is rare in women during the reproductive years and rapidly increases after menopause, strongly suggesting that estrogen (E2) plays an important role in the prevention of ...
Pabon M +8 more
europepmc +6 more sources
Piper sarmentosum enhances fracture healing in ovariectomized osteoporotic rats: a radiological study [PDF]
, 2011 INTRODUCTION: Osteoporotic fractures are common during osteoporotic states. Piper sarmentosum extract is known to possess antioxidant and anti-inflammatory properties.
Das, Srijit +6 more
core +5 more sources
HT update: spotlight on estradiol/norethindrone acetate combination therapy [PDF]
, 2008 The goal of postmenopausal hormone therapy is to alleviate the symptoms that are associated with the loss of estrogen. Many formulations of estrogen and progestin are available, depending on the needs and circumstances of each individual woman.
Casey, Colleen L, Murray, Christine A
core +3 more sources
Reference Profile Correlation Reveals Estrogen-like Trancriptional Activity of Curcumin [PDF]
, 2010 Background: Several secondary metabolites from herbal nutrient products act as weak estrogens (phytoestrogens), competing with endogenous estrogen for binding to the estrogen receptors and inhibiting steroid converting enzymes.
Albini, Adriana +9 more
core +1 more source
Hormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomised trials [PDF]
, 2001 BACKGROUND: Hormone replacement therapy (HRT) is often seen as the treatment of choice for preventing fractures in women. We undertook a recent meta-analysis of randomised trials which suggested that HRT reduced non-vertebral fractures by 30%.
Bell-Syer, Sally E.M. +1 more
core +3 more sources
Treatment of symptoms of the menopause: an endocrine society clinical practice guideline [PDF]
, 2015 Objective: The objective of this document is to generate a practice guideline for the management and treatment of symptoms of the menopause. Participants: The Treatment of Symptoms of the Menopause Task Force included six experts, a methodologist, and
Davis, Susan R. +6 more
core +1 more source
Dydrogesterone and norethisterone regulate expression of lipoprotein lipase and hormones-sensitive lipase in human subcutaneous abdominal adipocytes [PDF]
, 2007 Aim: In premenopausal women, hyper-androgenicity is associated with central obesity and an increased cardiovascular risk. We investigated the effects of dydrogesterone (DYD)(a non-androgenic progestogen) and norethisterone (NET)(an androgenic progestogen)
Barnett, A. H. +5 more
core +1 more source
The Vaginal Microbiome Post-Menopause and Urinary Tract Infections [PDF]
, 2023 Background: Urinary Tract Infection (UTI) is a condition where pathogens invade the urinary tract and can travel up the urethra and into the bladder. UTIs occur more commonly in females compared to males and in the post-menopausal population this rate ...
Anolik, Rifke +2 more
core +1 more source
, 2007 Cutaneous ageing manifests itself as a progressive reduction in maximum function and reserve capacity of skin tissue. It is not a unique and uniform biological event. Skin comprises three layers: epidermis, dermis and subcutaneous tissue.
Brincat, Mark P. +2 more
core +1 more source
Estrogens and the heart. Do they help or hurt? How estrogen impacts the cardiovascular system [PDF]
, 2016 Extensive epidemiological observations, clinical mechanistic studies, and basic laboratory research have suggested that the incidence of Cardiovascular Disease (CVD) increases with menopause and that Hormone Replacement Therapy (HRT), or more ...
MODENA, Maria Grazia
core +1 more source